Detalhe da pesquisa
1.
Incidence and Impact of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients with Adenocarcinoma of the Esophagus Treated with Curative Intent.
World J Surg
; 47(1): 227-235, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264338
2.
Improvement in cognitive impairment following a 12-week aerobic exercise intervention in individuals with non-cirrhotic chronic hepatitis C.
J Viral Hepat
; 28(4): 637-650, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33372320
3.
Development and relative validation of a short food frequency questionnaire for assessing dietary intakes of non-alcoholic fatty liver disease patients.
Eur J Nutr
; 59(2): 571-580, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30805696
4.
Opt-out screening for HIV, hepatitis B and hepatitis C: observational study of screening acceptance, yield and treatment outcomes.
Emerg Med J
; 37(2): 102-105, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806726
5.
Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.
J Viral Hepat
; 26(6): 685-696, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739368
6.
Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.
J Hepatol
; 67(6): 1140-1147, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843656
7.
Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.
BMC Health Serv Res
; 17(1): 288, 2017 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424064
8.
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study.
BMC Infect Dis
; 15: 471, 2015 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26503519
9.
In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients.
J Transl Med
; 12: 206, 2014 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048205
10.
Patient perspectives about treatment preferences for obesity with complications.
Obes Sci Pract
; 10(1): e720, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263990
11.
The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.
Clin Infect Dis
; 56(2): 228-35, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23074309
12.
Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak.
Hepatology
; 53(2): 396-405, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21246583
13.
Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.
Gut
; 60(11): 1563-71, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21551190
14.
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease.
BMJ Open Gastroenterol
; 9(1)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35523460
15.
Cardiac Magnetic Resonance at 3.0 T in Patients With C282Y Homozygous Hereditary Hemochromatosis: Superiority of Radial and Circumferential Strain Over Cardiac T2* Measurements at Baseline and at Post Venesection Follow-up.
J Thorac Imaging
; 37(5): 300-306, 2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426858
16.
Differential Effects of Dietary versus Exercise Intervention on Intrahepatic MAIT Cells and Histological Features of NAFLD.
Nutrients
; 14(11)2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35683998
17.
High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme.
J Hepatol
; 65(2): 446-8, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27130842
18.
Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD).
BMJ Open Gastroenterol
; 8(1)2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168043
19.
Determinants of Physical Activity Engagement in Patients With Nonalcoholic Fatty Liver Disease: The Need for an Individualized Approach to Lifestyle Interventions.
Phys Ther
; 101(2)2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33104787
20.
Liver stiffness changes during meal times.
Hepatology
; 60(1): 432, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24990107